98 related articles for article (PubMed ID: 1855402)
1. Anticardiolipin antibodies in patients with acute myocardial infarction.
Tsai RT; Wang CR; Lee GL; Chen MY; Lee YT; Chuang CY; Chen CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 May; 24(2):213-20. PubMed ID: 1855402
[TBL] [Abstract][Full Text] [Related]
2. Anti-cardiolipin antibodies in ischaemic heart disease.
Klemp P; Cooper RC; Strauss FJ; Jordaan ER; Przybojewski JZ; Nel N
Clin Exp Immunol; 1988 Nov; 74(2):254-7. PubMed ID: 3224444
[TBL] [Abstract][Full Text] [Related]
3. Importance of serum anticardiolipin antibody levels in coronary heart disease.
Yilmaz E; Adalet K; Yilmaz G; Badur S; Erzengin F; Koylan N; Ozsaruhan O; Ertem G; Büyüköztürk K
Clin Cardiol; 1994 Mar; 17(3):117-21. PubMed ID: 8168279
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies in young myocardial infarction patients.
Mishra MN; Kalra R; Gupta MK
Indian J Biochem Biophys; 2007 Dec; 44(6):481-4. PubMed ID: 18320848
[TBL] [Abstract][Full Text] [Related]
5. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
Tebbe B; Orfanos CE
Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
[TBL] [Abstract][Full Text] [Related]
6. Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction.
Raghavan C; Ditchfield J; Taylor RJ; Haeney MR; Barnes PC
J Clin Pathol; 1993 Dec; 46(12):1113-5. PubMed ID: 8282835
[TBL] [Abstract][Full Text] [Related]
7. [Anticardiolipin antibody in cerebral infarction].
Kitagawa Y; Okayasu H; Matsuoka Y; Mihara B; Koto A
Rinsho Shinkeigaku; 1991 Apr; 31(4):391-5. PubMed ID: 1914323
[TBL] [Abstract][Full Text] [Related]
8. Anticardiolipin antibodies are no marker for survived myocardial infarction.
Eber B; Kronberger-Schaffer E; Brussee H; Klima G; Obernosterer A; Toporsch M; Dusleag J; Klein W
Klin Wochenschr; 1990 Jun; 68(12):594-6. PubMed ID: 2376955
[TBL] [Abstract][Full Text] [Related]
9. IgG-anticardiolipin-antibodies are markers for cerebral and peripheral artery disease.
Friehs I; Eber B; Friehs G; Langsteger W; Koch G
Vasa; 1992; 21(2):158-62. PubMed ID: 1621434
[TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study.
Zuckerman E; Toubi E; Shiran A; Sabo E; Shmuel Z; Golan TD; Abinader E; Yeshurun D
Am J Med; 1996 Oct; 101(4):381-6. PubMed ID: 8873508
[TBL] [Abstract][Full Text] [Related]
11. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators.
Bili A; Moss AJ; Francis CW; Zareba W; Watelet LF; Sanz I
Circulation; 2000 Sep; 102(11):1258-63. PubMed ID: 10982540
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin response and its association with infections in young and middle-aged patients with cerebral infarction.
Syrjänen J; Vaarala O; Iivanainen M; Palosuo T; Valtonen VV; Aho K
Acta Neurol Scand; 1988 Nov; 78(5):381-6. PubMed ID: 3218444
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke.
Sletnes KE; Smith P; Abdelnoor M; Arnesen H; Wisløff F
Lancet; 1992 Feb; 339(8791):451-3. PubMed ID: 1346819
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population.
Shi W; Krilis SA; Chong BH; Gordon S; Chesterman CN
Aust N Z J Med; 1990 Jun; 20(3):231-6. PubMed ID: 2115326
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin antibody: a marker of immune reactivity.
Hoppmann RA; Loeser R; Saluta G; Rothberger H
Clin Exp Rheumatol; 1989; 7(3):283-6. PubMed ID: 2788057
[TBL] [Abstract][Full Text] [Related]
16. [Connections between ischemic heart disease and anti-cardiolipin antibody positivity].
Ferlazzo B; Bonanno D; Quattrocchi P; Paino AM; Arrigo F
Minerva Cardioangiol; 1993 Apr; 41(4):113-7. PubMed ID: 8332265
[TBL] [Abstract][Full Text] [Related]
17. Anticardiolipin antibodies and acquired immunodeficiency syndrome: prognostic marker or association with HIV infection?
Coll Daroca J; Gutiérrez-Cebollada J; Yazbeck H; Bergés A; Rubiés-Prat J
Infection; 1992; 20(3):140-2. PubMed ID: 1644488
[TBL] [Abstract][Full Text] [Related]
18. Serologic response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction.
Mattila K; Vaarala O; Palosuo T; Malkamäki M; Valtonen V; Nieminen M; Aho K
Clin Immunol Immunopathol; 1989 Jun; 51(3):414-8. PubMed ID: 2721035
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin antibodies in Behçet's syndrome: a predictor of a more severe disease.
Pereira RM; Gonçalves CR; Bueno C; Meirelles Ede S; Cossermelli W; de Oliveira RM
Clin Rheumatol; 1989 Jun; 8(2):289-91. PubMed ID: 2758775
[TBL] [Abstract][Full Text] [Related]
20. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]